Trusopt (Dorzolamide Hydrochloride Ophthalmic) - Summary

TRUSOPT SUMMARY

TRUSOPT^®
(dorzolamide hydrochloride ophthalmic solution)
Sterile Ophthalmic Solution 2%

TRUSOPT (dorzolamide hydrochloride ophthalmic solution) is a carbonic anhydrase inhibitor formulated for topical ophthalmic use.

TRUSOPT Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

See all Trusopt indications & dosage >>

TRUSOPT NEWS HIGHLIGHTS

Published Studies Related to Trusopt (Dorzolamide Ophthalmic)

Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma. [2008.10]

A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma. [2008.04]

Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment. [2008.01]

Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes. [2007.11]

Comparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressure. [2007.04]

more >>

Clinical Trials Related to Trusopt (Dorzolamide Ophthalmic)

Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs [Completed]

MK0507A Phase III Double-Blind, Comparative Study [Completed]

Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost [Completed]

Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide [Recruiting]

24-Hour IOP Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-Angle Glaucoma [Completed]

more >>